| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 137751-1G |
|
NA |
(R)-6,6'-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C29H19Cl4O4P | |
| 137751-100MG |
|
NA |
(R)-6,6'-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H19Cl4O4P | |
| 137751-25MG |
|
NA |
(R)-6,6'-雙(3,5-二氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C29H19Cl4O4P | |
| 137742-1G |
|
1412439-84-9 |
(S)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C29H21N2O8P | |
| 137742-100MG |
|
1412439-84-9 |
(S)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H21N2O8P | |
| 137742-25MG |
|
1412439-84-9 |
(S)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C29H21N2O8P | |
| 137741-1G |
|
1352810-37-7 |
(R)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C29H21N2O8P | |
| 137741-100MG |
|
1352810-37-7 |
(R)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C29H21N2O8P | |
| 137741-25MG |
|
1352810-37-7 |
(R)-6,6'-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C29H21N2O8P | |
| 137732-1G |
|
NA |
(S)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C31H27O6P | |
| 137732-100MG |
|
NA |
(S)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C31H27O6P | |
| 137732-25MG |
|
NA |
(S)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C31H27O6P | |
| 137731-1G |
|
NA |
(R)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C31H27O6P | |
| 137731-100MG |
|
NA |
(R)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C31H27O6P | |
| 137731-25MG |
|
NA |
(R)-6,6'-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C31H27O6P | |
| 137722-1G |
|
NA |
(S)-6,6'-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C31H21F6O4P | |
| 137722-100MG |
|
NA |
(S)-6,6'-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C31H21F6O4P | |
| 137722-25MG |
|
NA |
(S)-6,6'-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C31H21F6O4P | |
| 137721-1G |
|
NA |
(R)-6,6'-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C31H21F6O4P | |
| 137721-100MG |
|
NA |
(R)-6,6'-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C31H21F6O4P | |
小泰
|
010-60710855
|